Rui Hu
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 6
-
- Cardiomyopathy and Myosin Studies 8
- Cardiac Valve Diseases and Treatments 8
- Cardiovascular Function and Risk Factors 6
-
- Aortic Disease and Treatment Approaches 12
- Aortic aneurysm repair treatments 7
- Neurology top 10%
-
- Cardiac Structural Anomalies and Repair 6
- Cardiac and Coronary Surgery Techniques 6
- Cited by
- Infectious DiseasesCardiology and Cardiovascular MedicineApplied Microbiology and Biotechnology
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Rui Hu
85 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 118
- Infectious Diseases 299
- Cardiology and Cardiovascular Medicine 300
- Applied Microbiology and Biotechnology 20
- Pulmonary and Respiratory Medicine 306
- Neurology 140
Countries citing papers authored by Rui Hu
This map shows the geographic impact of Rui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Hu more than expected).
Fields of papers citing papers by Rui Hu
This network shows the impact of papers produced by Rui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Hu. The network helps show where Rui Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rui Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 46 | |
| 9 | 2021 | 48 | |
| 10 | 2021 | 4 | |
| 11 | 2019 | 15 | |
| 12 | 2019 | 7 | |
| 13 | 2019 | 57 | |
| 14 | 2019 | 2 | |
| 15 | 2018 | 23 | |
| 16 | 2017 | 6 | |
| 17 | 2017 | 10 | |
| 18 | 2014 | 17 | |
| 19 | [Fechtner syndrome, a nonmuscle myosin heavy chain 9 gene mutation related disease: a case report and literature review]. | 2011 | 0 |
| 20 | 2008 | 21 |
About Rui Hu
Rui Hu is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 92 papers that have together received 1.4k indexed citations. Recurring topics across this work include Aortic Disease and Treatment Approaches (12 papers), Cardiomyopathy and Myosin Studies (8 papers), Cardiac Valve Diseases and Treatments (8 papers), Aortic aneurysm repair treatments (7 papers), Cardiac Structural Anomalies and Repair (6 papers), Cardiovascular Function and Risk Factors (6 papers), COVID-19 Clinical Research Studies (6 papers) and Cardiac and Coronary Surgery Techniques (6 papers). The work is most often cited by research in Infectious Diseases (299 citations), Cardiology and Cardiovascular Medicine (300 citations) and Applied Microbiology and Biotechnology (20 citations). Rui Hu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shiyao Pei, Xiang Chen, Chaofei Han, Mingzhu Yin, Zhiyong Wu, Zhiwei Wang, Xiao Hu, Hongbing Wu, Wei Ren and Xiaoyang Zhou.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.